### Analysis of rs587782044 in the CDH1 Gene

The variant **rs587782044** is located in the **CDH1** gene, which encodes E-cadherin, a protein critical for cell-cell adhesion and tumor suppression. Below is a detailed analysis of this variant and how it differs from other known variants in the same gene.

---

### 1. **Variant Identification**
- **rs Number**: [rs587782044](https://identifiers.org/dbsnp/rs587782044)
- **Gene**: CDH1
- **HGVS Notations**:
  - For the G>A substitution:
    - **Genomic**: chr16:g.68819401G>A
    - **Transcript**: ENST00000261769.10:c.1687G>A
    - **Protein**: ENSP00000261769.4:p.Ala563Thr
  - For the G>T substitution:
    - **Genomic**: chr16:g.68819401G>T
    - **Transcript**: ENST00000261769.10:c.1687G>T
    - **Protein**: ENSP00000261769.4:p.Ala563Ser

---

### 2. **Disease Associations**
- **G>A substitution**:
  - Associated with **Hereditary cancer-predisposing syndrome** ([ClinVar entry](https://www.ncbi.nlm.nih.gov/clinvar/variation/481681)).
  - Predictive models:
    - **SIFT**: 0.0 (deleterious)
    - **PolyPhen**: 0.974 (probably damaging)
    - **AlphaMissense**: 0.136 (low pathogenicity)
- **G>T substitution**:
  - Associated with:
    - **Hereditary cancer-predisposing syndrome**
    - **Hereditary diffuse gastric adenocarcinoma** ([ClinVar entry](https://www.ncbi.nlm.nih.gov/clinvar/variation/141834)).
  - Predictive models:
    - **SIFT**: 0.01 (deleterious)
    - **PolyPhen**: 0.987 (probably damaging)
    - **AlphaMissense**: 0.1621 (low pathogenicity)

---

### 3. **Literature Evidence**
- No specific publications were retrieved for rs587782044. However, the **CDH1** gene is well-documented in the context of hereditary diffuse gastric cancer (HDGC) and lobular breast cancer.

---

### 4. **Allele Frequency Comparison**
- **G>A substitution**: No allele frequency data available.
- **G>T substitution**:
  - **gnomAD Exomes**: 0.0000027 (very rare)
  - **gnomAD Genomes**: 0.0000394 (very rare)
  - This variant is extremely rare in both Japanese and non-Japanese populations, with no population-specific enrichment reported.

---

### 5. **GWAS Findings**
- No GWAS studies specifically link rs587782044 to phenotypes. However, other variants in **CDH1** are strongly associated with hereditary diffuse gastric cancer and other cancers.

---

### 6. **TogoVar Link**
- [TogoVar page for rs587782044](https://togovar.org)

---

### Comparison with Other Variants in CDH1
1. **Functional Impact**:
   - rs587782044 (both G>A and G>T) results in missense changes (Ala563Thr and Ala563Ser), which are predicted to be damaging to protein function.
   - Other pathogenic variants in **CDH1** include nonsense mutations, frameshift insertions/deletions, and splice-site variants, which often lead to loss of function.

2. **Disease Specificity**:
   - rs587782044 is associated with hereditary cancer syndromes, similar to other pathogenic variants in **CDH1**.
   - However, some variants in **CDH1** are more specifically linked to hereditary diffuse gastric cancer (HDGC) or lobular breast cancer.

3. **Allele Frequency**:
   - rs587782044 is extremely rare, consistent with other pathogenic variants in **CDH1**, which are typically rare due to their strong association with severe disease phenotypes.

4. **Predictive Models**:
   - rs587782044 shows high PolyPhen and low SIFT scores, indicating a likely damaging effect. This is consistent with other pathogenic missense variants in **CDH1**.

---

### Summary
The variant rs587782044 is a rare missense variant in the **CDH1** gene, associated with hereditary cancer syndromes. It differs from other known variants in **CDH1** in its specific amino acid change (Ala563Thr or Ala563Ser) and its rarity. While it shares functional and disease-related characteristics with other pathogenic variants, its exact clinical significance may require further functional studies.

---

### 日本語での説明

#### 1. **変異の特定**
- **rs番号**: [rs587782044](https://identifiers.org/dbsnp/rs587782044)
- **遺伝子**: CDH1
- **HGVS表記**:
  - G>A置換:
    - **ゲノム**: chr16:g.68819401G>A
    - **転写産物**: ENST00000261769.10:c.1687G>A
    - **タンパク質**: ENSP00000261769.4:p.Ala563Thr
  - G>T置換:
    - **ゲノム**: chr16:g.68819401G>T
    - **転写産物**: ENST00000261769.10:c.1687G>T
    - **タンパク質**: ENSP00000261769.4:p.Ala563Ser

---

#### 2. **疾患との関連**
- **G>A置換**:
  - **遺伝性がん素因症候群**と関連 ([ClinVarエントリ](https://www.ncbi.nlm.nih.gov/clinvar/variation/481681))
  - 予測モデル:
    - **SIFT**: 0.0 (有害)
    - **PolyPhen**: 0.974 (おそらく有害)
    - **AlphaMissense**: 0.136 (低病原性)
- **G>T置換**:
  - 関連疾患:
    - **遺伝性がん素因症候群**
    - **遺伝性びまん性胃腺癌** ([ClinVarエントリ](https://www.ncbi.nlm.nih.gov/clinvar/variation/141834))
  - 予測モデル:
    - **SIFT**: 0.01 (有害)
    - **PolyPhen**: 0.987 (おそらく有害)
    - **AlphaMissense**: 0.1621 (低病原性)

---

#### 3. **文献エビデンス**
- rs587782044に特化した文献は見つかりませんでしたが、**CDH1**遺伝子は遺伝性びまん性胃癌（HDGC）や小葉性乳癌に関連することが広く知られています。

---

#### 4. **アレル頻度の比較**
- **G>A置換**: アレル頻度データなし。
- **G>T置換**:
  - **gnomAD Exomes**: 0.0000027 (非常に稀)
  - **gnomAD Genomes**: 0.0000394 (非常に稀)
  - 日本人と非日本人集団の間で特定の頻度差は報告されていません。

---

#### 5. **GWASの発見**
- rs587782044に関連するGWAS研究はありません。ただし、**CDH1**の他の変異は遺伝性びまん性胃癌や他のがんと強く関連しています。

---

#### 6. **TogoVarリンク**
- [TogoVarページ (rs587782044)](https://togovar.org)

---

#### 他のCDH1変異との比較
1. **機能的影響**:
   - rs587782044はミスセンス変異（Ala563ThrおよびAla563Ser）を引き起こし、タンパク質機能に有害であると予測されています。
   - 他の病原性変異にはナンセンス変異、フレームシフト挿入/欠失、スプライス部位変異が含まれ、これらは通常機能喪失を引き起こします。

2. **疾患特異性**:
   - rs587782044は遺伝性がん症候群と関連していますが、他の変異は遺伝性びまん性胃癌（HDGC）や小葉性乳癌に特異的に関連する場合があります。

3. **アレル頻度**:
   - rs587782044は非常に稀であり、他の病原性変異と一致しています。

4. **予測モデル**:
   - rs587782044はPolyPhenスコアが高く、SIFTスコアが低いことから、有害である可能性が高いとされています。

---

#### まとめ
rs587782044は**CDH1**遺伝子の稀なミスセンス変異であり、遺伝性がん症候群と関連しています。他の病原性変異と同様に、機能的および疾患関連の特徴を共有していますが、特定のアミノ酸変化（Ala563ThrまたはAla563Ser）によって区別されます。